Reactions Weekly

, Volume 1633, Issue 1, pp 340–340 | Cite as

Fosamprenavir/ritonavir

Hypercholesterolaemia, dyslipidaemia and elevated ALT: 2 case reports
Case report
  • 19 Downloads

Reference

  1. Judd A, et al. Post-licensing safety of fosamprenavir in HIV-infected children in Europe. Pharmacoepidemiology and Drug Safety 23: 321-325, No. 3, Mar 2014. Available from: URL: http://doi.org/10.1002/pds.3543 - UnitedKingdom

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations